Each molecularly defined population of patients with steatosis [Clusters (CL) A, B, and C] was characterized by certain hepatic and clinical-metabolic alterations. Relevant clinical parameters associated to each cluster of patients were grouped according to their expression levels of the spliceosome components and splicing factors. Values represent the means ± SEM. Asterisks indicate values that significantly differ between groups (t test: *P < 0.05, **P < 0.01). AST, aspartate transaminase; GGT, gamma-glutamyltransferase; NON ST, without steatosis.